<?xml version="1.0" ?>
<text author="Martina La Spina, Eva Galletta, Michele Azzolini, Saioa Gomez Zorita, Sofia Parrasia, Marika Salvalaio, Andrea Salmaso, Lucia Biasutto" dateCollected="2019-11-03" id="amalgum_academic_doc044" shortTile="browning-effects" sourceURL="https://www.mdpi.com/1422-0067/20/21/5377/htm" speakerCount="0" speakerList="none" title="Browning Effects of a Chronic Pterostilbene Supplementation in Mice Fed a High-Fat Diet" type="academic">
<head>
<s type="frag">
1.	LS	@ord@
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Obesity	NN	obesity
and	CC	and
related	VBN	relate
disorders	NNS	disorder
are	VBP	be
widely	RB	widely
perceived	VBN	perceive
by	IN	by
both	CC	both
the	DT	the
public	NN	public
and	CC	and
the	DT	the
scientific	JJ	scientific
community	NN	community
as	IN	as
a	DT	a
major	JJ	major
and	CC	and
growing	VBG	grow
threat	NN	threat
to	TO	to
global	JJ	global
human	JJ	human
health	NN	health
;	:	;
more	JJR	more
than	IN	than
2	CD	2
billion	NN	billion
people	NNS	people
worldwide	NN	worldwide
are	VBP	be
currently	RB	currently
overweight	JJ	overweight
or	CC	or
obese	JJ	obese
,	,	,
and	CC	and
obesity	NN	obesity
is	VBZ	be
associated	VBN	associate
with	IN	with
an	DT	an
increased	VBN	increase
hazard	NN	hazard
for	IN	for
a	DT	a
range	NN	range
of	IN	of
ailments	NNS	ailment
,	,	,
including	VBG	include
type-2	JJ	type-2
diabetes	NNS	diabete
,	,	,
cardiovascular	NN	cardiovascular
diseases	NNS	disease
and	CC	and
hypertension	NN	hypertension
,	,	,
multiple	JJ	multiple
cancer	NN	cancer
types	NNS	type
,	,	,
chronic	JJ	chronic
inflammatory	JJ	inflammatory
diseases	NNS	disease
,	,	,
dementia	NN	dementia
,	,	,
and	CC	and
neurodegenerative	JJ	neurodegenerative
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
All	PDT	all
these	DT	these
complications	NNS	complication
lead	VBP	lead
to	TO	to
a	DT	a
shortened	VBN	shorten
life	NN	life
expectancy	NN	expectancy
and	CC	and
have	VBP	have
a	DT	a
high	JJ	high
economic	JJ	economic
impact	NN	impact
on	IN	on
healthcare	NN	healthcare
systems	NNS	system
.	.	.
</s>
</p>
<p>
<s type="decl">
Lifestyle	NN	Lifestyle
changes	NNS	change
(	-LRB-	(
such	JJ	such
as	IN	as
diet	NN	diet
modification	NN	modification
,	,	,
physical	JJ	physical
activity	NN	activity
,	,	,
and	CC	and
behavioral	JJ	behavioral
interventions	NNS	intervention
)	-RRB-	)
are	VBP	be
the	DT	the
cornerstones	NNS	cornerstone
of	IN	of
obesity	NN	obesity
treatment	NN	treatment
but	CC	but
maintaining	VBG	maintain
a	DT	a
healthy	JJ	healthy
lifestyle	NN	lifestyle
is	VBZ	be
often	RB	often
perceived	VBN	perceive
as	IN	as
challenging	VBG	challenge
.	.	.
</s>
<s type="decl">
Alternatively	RB	alternatively
,	,	,
pharmacotherapy	NN	pharmacotherapy
and	CC	and
bariatric	NN	bariatric
surgery	NN	surgery
represent	VBP	represent
more	RBR	more
“	``	&quot;
aggressive	JJ	aggressive
”	&apos;&apos;	&quot;
interventions	NNS	intervention
,	,	,
and	CC	and
are	VBP	be
applicable	JJ	applicable
only	RB	only
if	IN	if
the	DT	the
problem	NN	problem
is	VBZ	be
severe	JJ	severe
.	.	.
</s>
<s type="decl">
Current	JJ	Current
pharmacotherapy	NN	pharmacotherapy
for	IN	for
obesity	NN	obesity
relies	VBZ	rely
on	IN	on
a	DT	a
few	JJ	few
drugs	NNS	drug
that	WDT	that
are	VBP	be
approved	VBN	approve
only	RB	only
for	IN	for
patients	NNS	patient
with	IN	with
BMI	NNP	BMI
&gt;	SYM	&gt;
30	CD	@card@
.	.	.
</s>
<s type="decl">
With	IN	with
the	DT	the
only	JJ	only
exception	NN	exception
of	IN	of
orlistat	NN	orlistat
(	-LRB-	(
which	WDT	which
decreases	VBZ	decrease
fat	NN	fat
absorption	NN	absorption
by	IN	by
inhibiting	VBG	inhibiting
lipases	NNS	lipase
)	-RRB-	)
,	,	,
most	JJS	most
of	IN	of
these	DT	these
drugs	NNS	drug
act	VBP	act
through	IN	through
the	DT	the
central	JJ	central
nervous	JJ	nervous
system	NN	system
to	TO	to
reduce	VB	reduce
food	NN	food
intake	NN	intake
(	-LRB-	(
via	IN	via
reduction	NN	reduction
of	IN	of
appetite	NN	appetite
or	CC	or
enhancement	NN	enhancement
of	IN	of
satiety	NN	satiety
)	-RRB-	)
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
use	NN	use
of	IN	of
these	DT	these
treatments	NNS	treatment
may	MD	may
lead	VB	lead
to	TO	to
severe	JJ	severe
adverse	JJ	adverse
effects	NNS	effect
and	CC	and
a	DT	a
long-term	NN	long-term
prescription	NN	prescription
is	VBZ	be
usually	RB	usually
not	RB	not
recommended	VBN	recommend
.	.	.
</s>
</p>
<p>
<s type="sub">
A	DT	a
nutraceutical	JJ	nutraceutical
approach	NN	approach
could	MD	could
be	VB	be
a	DT	a
useful	JJ	useful
supporting	VBG	support
tool	NN	tool
to	TO	to
treat	VB	treat
overweight	JJ	overweight
people	NNS	people
,	,	,
since	IN	since
the	DT	the
use	NN	use
of	IN	of
natural	JJ	natural
compounds	NNS	compound
offers	VBZ	offer
clear	JJ	clear
advantages	NNS	advantage
over	IN	over
drug	NN	drug
treatments	NNS	treatment
in	IN	in
terms	NNS	term
of	IN	of
adverse	NN	adverse
side	NN	side
effects	NNS	effect
,	,	,
suitability	NN	suitability
for	IN	for
chronic	JJ	chronic
treatments	NNS	treatment
,	,	,
marketability	NN	marketability
,	,	,
and	CC	and
safety	NN	safety
.	.	.
</s>
<s type="decl">
Here	RB	here
we	PRP	we
focus	VBP	focus
our	PRP$	our
attention	NN	attention
on	IN	on
pterostilbene	NN	pterostilbene
(	-LRB-	(
Pt	NNP	Pt
;	:	;
3,5-dimethylresveratrol	NN	3,5-dimethylresveratrol
)	-RRB-	)
,	,	,
an	DT	an
analogue	NN	analogue
of	IN	of
resveratrol	NN	resveratrol
that	WDT	that
differs	VBZ	differ
from	IN	from
the	DT	the
latter	JJR	latter
for	IN	for
the	DT	the
presence	NN	presence
of	IN	of
two	CD	two
methyl	NN	methyl
groups	NNS	group
.	.	.
</s>
<s type="frag">
Its	PRP$	its
increased	JJ	increase
lipophilicity	NN	lipophilicity
accounts	NNS	account
for	IN	for
its	PRP$	its
ability	NN	ability
to	TO	to
reach	VB	reach
higher	JJR	high
tissue	NN	tissue
levels	NNS	level
in	IN	in
comparison	NN	comparison
to	TO	to
resveratrol	NN	resveratrol
’s	POS	&apos;s
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
there	EX	there
is	VBZ	be
no	DT	no
concern	NN	concern
about	IN	about
its	PRP$	its
safety	NN	safety
.	.	.
</s>
<s type="decl">
Pterostilbene	NN	Pterostilbene
has	VBZ	have
already	RB	already
been	VBN	be
shown	VBN	show
to	TO	to
have	VB	have
positive	JJ	positive
effects	NNS	effect
in	IN	in
combating	VBG	combate
obesity	NN	obesity
and	CC	and
related	VBN	relate
disorders	NNS	disorder
.	.	.
</s>
<s type="decl">
In	IN	in
rat	NN	rut
models	NNS	model
of	IN	of
obesity	NN	obesity
,	,	,
Pt	NNP	Pt
reduces	VBZ	reduce
fat	NN	fat
accumulation	NN	accumulation
and	CC	and
ameliorates	VBZ	ameliorate
liver	NN	liver
steatosis	NN	steatosis
modulating	NN	modulate
lipolysis	NN	lipolysis
,	,	,
lipogenesis	NN	lipogenesis
,	,	,
fatty	NN	fatty
acid	NN	acid
oxidation	NN	oxidation
,	,	,
improves	VBZ	improve
glycemic	NN	glycemic
control	NN	control
by	IN	by
modulating	VBG	modulate
glycolysis	NN	glycolysis
,	,	,
gluconeogenesis	NN	gluconeogenesis
,	,	,
and	CC	and
glucose	NN	glucose
uptake	NN	uptake
,	,	,
increases	VBZ	increase
thermogenic	NN	thermogenic
markers	NNS	marker
in	IN	in
brown	JJ	brown
adipose	NN	adipose
tissue	NN	tissue
,	,	,
and	CC	and
induces	VBZ	induce
changes	NNS	change
in	IN	in
the	DT	the
gut	NN	get
microbiota	NN	microbiota
towards	IN	towards
a	DT	a
healthier	JJR	healthier
composition	NN	composition
.	.	.
</s>
<s type="decl">
Furthermore	RB	furthermore
,	,	,
Pt	NNP	Pt
exerts	VBZ	exert
its	PRP$	its
beneficial	JJ	beneficial
effects	NNS	effect
combating	VBG	combate
adipose	NN	adipose
tissue	NN	tissue
inflammation	NN	inflammation
.	.	.
</s>
</p>
<p>
<s type="decl">
An	DT	an
interesting	JJ	interesting
therapeutic	JJ	therapeutic
target	NN	target
for	IN	for
treating	VBG	treat
obesity	NN	obesity
and	CC	and
metabolic	NN	metabolic
syndrome	NN	syndrome
is	VBZ	be
represented	VBN	represent
by	IN	by
beige	NN	beige
(	-LRB-	(
or	CC	or
brite	NN	brite
,	,	,
i.	FW	i.
e.	FW	e.
,	,	,
brown-in-white	NN	brown-in-white
)	-RRB-	)
adipocytes	NNS	adipocyte
.	.	.
</s>
<s type="decl">
These	DT	these
cells	NNS	cell
are	VBP	be
an	DT	an
inducible	JJ	inducible
form	NN	form
of	IN	of
thermogenic	NN	thermogenic
adipocytes	NNS	adipocyte
residing	VBG	reside
in	IN	in
subcutaneous	JJ	subcutaneous
white	JJ	white
adipose	NN	adipose
tissue	NN	tissue
(	-LRB-	(
WAT	NNP	WAT
)	-RRB-	)
and	CC	and
are	VBP	be
also	RB	also
found	VBN	find
in	IN	in
human	JJ	human
adults	NNS	adult
.	.	.
</s>
<s type="decl">
Beige	JJ	Beige
adipocytes	NNS	adipocyte
can	MD	can
derive	VB	derive
from	IN	from
white	JJ	white
adipocyte	NN	adipocyte
trans	NN	tran
differentiation	NN	differentiation
and	CC	and
from	IN	from
the	DT	the
differentiation	NN	differentiation
of	IN	of
adipogenic	JJ	adipogenic
progenitor	NN	progenitor
cells	NNS	cell
.	.	.
</s>
<s type="decl">
They	PRP	they
express	VBP	express
a	DT	a
set	NN	set
of	IN	of
beige-specific	JJ	beige-specific
genes	NNS	gene
,	,	,
such	JJ	such
as	IN	as
<hi rend="italic">
Cited1	NNP	Cited1
</hi>
and	CC	and
<hi rend="italic">
Tbx1	NNP	Tbx1
</hi>
,	,	,
but	CC	but
also	RB	also
have	VBP	have
similarities	NNS	similarity
with	IN	with
brown	JJ	brown
adipocytes	NNS	adipocyte
,	,	,
including	VBG	include
abundant	JJ	abundant
mitochondria	NN	mitochondria
,	,	,
multilocular	JJ	multilocular
lipid	NN	lipid
droplets	NNS	droplet
and	CC	and
expression	NN	expression
of	IN	of
brown-specific	JJ	brown-specific
genes	NNS	gene
such	JJ	such
as	IN	as
<hi rend="italic">
uncoupling	NN	uncoupling
protein	NN	protein
1	CD	1
</hi>
(	-LRB-	(
<hi rend="italic">
UCP1	NNP	UCP1
</hi>
)	-RRB-	)
and	CC	and
<hi rend="italic">
Cidea	NNP	Cidea
</hi>
;	:	;
similar	JJ	similar
to	TO	to
brown	JJ	brown
adipocytes	NNS	adipocyte
,	,	,
they	PRP	they
are	VBP	be
able	JJ	able
to	TO	to
dissipate	VB	dissipate
energy	NN	energy
as	IN	as
heat	NN	heat
.	.	.
</s>
<s type="sub">
Induction	NN	induction
of	IN	of
beige	JJ	beige
adipocytes	NNS	adipocyte
(	-LRB-	(
i.	FW	i.
e.	FW	e.
,	,	,
WAT	NNP	WAT
browning	NN	browning
)	-RRB-	)
can	MD	can
be	VB	be
induced	VBN	induce
by	IN	by
environmental	JJ	environmental
or	CC	or
physiological	JJ	physiological
stimuli	NNS	stimulus
(	-LRB-	(
such	JJ	such
as	IN	as
cold	JJ	cold
exposure	NN	exposure
,	,	,
physical	JJ	physical
activity	NN	activity
,	,	,
or	CC	or
thyroid	NN	thyroid
hormones	NNS	hormone
)	-RRB-	)
,	,	,
but	CC	but
also	RB	also
pharmacologically	RB	pharmacologically
(	-LRB-	(
for	IN	for
example	NN	example
,	,	,
with	IN	with
PPAR	NNP	PPAR
agonists	NNS	agonist
)	-RRB-	)
,	,	,
and	CC	and
could	MD	could
prevent	VB	prevent
or	CC	or
combat	VB	combat
obesity	NN	obesity
by	IN	by
increasing	VBG	increase
energy	NN	energy
consumption	NN	consumption
through	IN	through
non-shivering	JJ	non-shivering
thermogenesis	NN	thermogenesis
.	.	.
</s>
</p>
<p>
<s type="decl">
Various	JJ	Various
phytochemicals	NNS	phytochemical
have	VBP	have
been	VBN	be
reported	VBN	report
to	TO	to
promote	VB	promote
fat	NN	fat
browning	NN	browning
.	.	.
</s>
<s type="decl">
The	DT	the
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
was	VBD	be
to	TO	to
investigate	VB	investigate
the	DT	the
ability	NN	ability
of	IN	of
Pt	NNP	Pt
to	TO	to
do	VB	do
it	PRP	it
in	IN	in
WAT	NNP	WAT
.	.	.
</s>
<s type="decl">
Its	PRP$	its
effects	NNS	effect
were	VBD	be
first	RB	first
assayed	VBN	assay
on	IN	on
cultured	VBN	culture
3T3-L1	CD	3T3-L1
adipocytes	NNS	adipocyte
,	,	,
and	CC	and
then	RB	then
in	IN	in
a	DT	a
mouse	NN	mouse
model	NN	model
of	IN	of
diet-induced	JJ	diet-induced
obesity	NN	obesity
.	.	.
</s>
<s type="decl">
To	TO	To
take	VB	take
into	IN	into
account	NN	account
possible	JJ	possible
gender-specific	JJ	gender-specific
differences	NNS	difference
,	,	,
both	DT	both
females	NNS	female
and	CC	and
males	NNS	male
were	VBD	be
included	VBN	include
in	IN	in
our	PRP$	our
experimental	JJ	experimental
groups	NNS	group
;	:	;
a	DT	a
30	CD	@card@
week-long	JJ	week-long
treatment	NN	treatment
was	VBD	be
performed	VBN	perform
,	,	,
to	TO	to
highlight	VB	highlight
long-term	NN	long-term
effects	NNS	effect
of	IN	of
a	DT	a
chronic	JJ	chronic
Pt	NN	Pt
supplementation	NN	supplementation
.	.	.
</s>
<s type="decl">
We	PRP	we
found	VBD	find
that	IN	that
Pt	NNP	Pt
diminished	JJ	diminish
body	NN	body
weight	NN	weight
gain	NN	gain
induced	VBN	induce
by	IN	by
a	DT	a
high-fat	JJ	high-fat
diet	NN	diet
regimen	NN	regimen
;	:	;
also	RB	also
,	,	,
glucose	NN	glucose
homeostasis	NN	homeostasis
was	VBD	be
partially	RB	partially
preserved	VBN	preserve
,	,	,
at	IN	at
least	JJS	least
up	RP	up
to	TO	to
week	NN	week
18	CD	@card@
.	.	.
</s>
<s type="decl">
Interestingly	RB	Interestingly
,	,	,
Pt	NNP	Pt
was	VBD	be
able	JJ	able
to	TO	to
induce	VB	induce
WAT	NNP	WAT
browning	VBG	browning
,	,	,
leading	VBG	lead
to	TO	to
an	DT	an
increase	NN	increase
in	IN	in
the	DT	the
transcription	NN	transcription
of	IN	of
beige-	NN	beige-
and	CC	and
brown-related	JJ	brown-related
genes	NNS	gene
and	CC	and
of	IN	of
UCP1	NNP	UCP1
protein	NN	protein
levels	NNS	level
,	,	,
which	WDT	which
,	,	,
however	RB	however
,	,	,
did	VBD	do
not	RB	not
achieve	VB	achieve
significance	NN	significance
.	.	.
</s>
</p>
</text>
